MENU
NEWS
RESEARCH
CRUKMI logo image CRUKMI logo image

WORLD CLASS BASIC, TRANSLATIONAL AND CLINICAL RESEARCH

News

 

Institute researcher invited to give prestigious conference lecture

30 January 2018

Dr Amaya Virós from the Cancer Research UK Manchester Institute has been chosen to deliver the Rising Star Lecture as the representative of the European Society for Dermatological Research (ESDR) at the 2018 International Investigative Dermatology Meeting.

Every five years the scientific meeting of the Society for Investigative Dermatology (SID) is held in conjunction with the ESDR and the Japanese Society for Investigative Dermatology (JSID), and is known as "International Investigative Dermatology (IID)". 

The IID meeting Rising Stars Lectures celebrate the best of emerging dermatological science throughout the world.

Program committees from SID, JSID and ESDR each select one prominent young researcher engaged in high-impact science in their respective regions to provide a short overview on their current work.

Dr Virós obtained her degree in Medicine and Surgery at the University of Barcelona. She completed her training in dermatology and venereology at Vall d’Hebrón University Hospital, Spain. She then obtained a Fulbright Scholarship to become a Fellow in the Department of Dermatology and Pathology at the University of California, San Francisco, in the laboratory of Boris Bastian. She next moved to Professor Richard Marais’ laboratory, first to the Institute of Cancer Research in London and then at the Cancer Research UK Manchester Institute where she obtained her PhD.

Amaya has combined her research with clinical work as a dermatologist at St. George’s Hospital, London, and Salford Royal NHS Foundation Trust in Manchester. Her research has focused on the mechanisms driving secondary keratinocytic tumours in metastatic melanoma patients treated with the BRAF inhibitor vemurafenib, as well as on dissecting the specific contribution of ultraviolet radiation to distinct subtypes of melanoma defined by their driver oncogene.

In 2016, she became a Wellcome Trust Intermediate Clinician Scientist Fellow and is establishing her research group as an Institute Fellow at CRUK MI. Her lab focuses on how ageing influences melanoma initiation and progression and developing rationales of adjuvant care for patients at high risk for melanoma progression.